United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$235.95 USD
-1.05 (-0.44%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $235.99 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: BMO |
3/2024 | $5.63 | 0.91% |
Earnings Summary
For their last quarter, United Therapeutics (UTHR) reported earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.92 per share. This reflects a positive earnings surprise of 11.22%. Look out for UTHR's next earnings release on May 01, 2024. For the next earning release, we expect the company to report earnings of $5.63 per share, reflecting a year-over-year increase of 15.84%.
Earnings History
Price & Consensus
Zacks News for UTHR
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services